Fig. 9
Uptake efficiency and mode of cellular entry
(A) Uptake efficiency of NGP ASO, NGP Scr, NP ASO, and Bodipy. (B) NGP ASO shows dose-dependent increase in cellular entry to reach 100% saturation at 50 nM. (C) Time-dependent increase in uptake efficiency; 100% saturation after 1-h exposure duration at both 500 and 1,000 nM. (D) Flow cytometry results of NGP ASO-BODIPY uptake after use of chloroquine, chlorpromazine, amiloride, and genistein. (E) Western blot analysis of NANOG in MCF7 cells after treatment with NGP ASO/NPASO alone and in combination with chloroquine. (F) Immunoblot analysis of NANOG in MCF7 cells after treatment with NGP ASO/NPASO alone and in combination with amiloride, genistein, and chlorpromazine. Data presented as mean ± SEM. ?p < 0.05.